About Proteomics
Proteomics is a systematic study of proteins on a large scale, particularly their functions and structures. Proteomics has the potential to answer some key questions that were unsolved by genomics, because proteins are the functional unit of cells. Proteomics research is enhanced by both protein and DNA sequence databases, advances in mass spectrometry, and development of computer algorithms for database searching. The most common application of proteomics is the analysis of target proteins. Proteomics requires various instruments, consumables, reagents, media, and software for protein identification, purification, quantification, and investigation of the interaction between various proteins. Proteins can undergo post-translational modifications to form three-dimensional structures, which can easily be identified by proteomics.
TechNavio's analysts forecast the Global Proteomics market to grow at a CAGR of 8.39 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Proteomics market for the period 2015–2019. The market can be divided into two segments: Equipment and Consumables.
TechNavio's report, the Global Proteomics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the Global Proteomics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Agilent Technologies
• Danaher
• Thermo Fischer Scientific
Other Prominent Vendors
• AB Sciex
• Abbott Laboratories
• Affymetrix
• AMS Biotechnology
• Avacta Life Sciences
• BD Biosciences
• Biocompare
• Bio-Rad
• Bio-WORLD
• Bruker Daltonics
• Caprion Proteomics
• Cellzome AG
• Dionex
• GE Healthcare Life Sciences
• Flowgen Bioscience
• Fluidigm
• Illumina
• MRM Proteomics
• Ocular Proteomics
• Perkin Elmer
• Pragati Biomedical
• Proteomics International
• Proteomics Sciences
• Roche Diagnostics
• Sera Proteomics
• Shimadzu
• SGS
• Sigma-Aldrich
• Waters
• Xencor
Market Driver
• Increase in Demand for Personalized Medicines
• For a full, detailed list, view our report
Market Challenge
• Ethical, Privacy, and Practical Issues
• For a full, detailed list, view our report
Market Trend
• Shift from Genomics to Proteomics
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
06. Overview
06.1 Laboratory applications of proteomic technologies
06.2 Healthcare applications of proteomics
06.2.1 Oncoproteomics
06.2.2 Neuroproteomics
06.3 Medicinal applications of proteomics-based biomarkers
06.4 Technologies for proteomics workflow
07. Pricing and Reimbursement Scenario
07.1 Pricing
07.2 Reimbursement
07.2.1 The US molecular diagnostics reimbursement structure
07.2.2 The European molecular diagnostics reimbursement structure
08. Leading Equipment for Proteomics
08.1 Mass spectrometry
08.2 2-D electrophoresis
08.3 Protein biochips
09. International Proteomics Associations
09.1 Initiatives sponsored by Human Proteomics Organization
10. Market Landscape
10.1 Market overview
10.2 Market size and forecast
10.3 Five forces analysis
11. Global Categorization of Detected Human Plasma Proteins
12. Market Segmentation by Category
12.1 Proteomics market for mass spectrometry
12.2 Proteomics market for 2-D electrophoresis
12.3 Proteomics market for protein biochips
12.4 Proteomics market for consumables
13. Geographical Segmentation
13.1 Proteomics market in Americas
13.1.1 Market size and forecast
13.2 Proteomics market in EMEA
13.2.1 Market size and forecast
13.3 Proteomics market in APAC
13.3.1 Market size and forecast
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market share analysis 2014
21.3 Other prominent vendors
22. Key Vendor Analysis
22.1 Agilent Technologies
22.1.1 Key facts
22.1.2 Business overview
22.1.3 Business segmentation by revenue 2013
22.1.4 Business segmentation by revenue 2012 and 2013
22.1.5 Geographical segmentation by revenue 2013
22.1.6 Business strategy
22.1.7 Recent developments
22.1.8 SWOT analysis
22.2 Danaher
22.2.1 Key facts
22.2.2 Business overview
22.2.3 Business segmentation
22.2.4 Revenue by business segmentation
22.2.5 Revenue comparison 2012 and 2013
22.2.6 Segmentation by geography
22.2.7 Business strategy
22.2.8 Key information
22.2.9 SWOT analysis
22.3 Thermo Fisher
22.3.1 Key facts
22.3.2 Business overview
22.3.3 Business segmentation
22.3.4 Business segmentation by revenue
22.3.5 Product segmentation by revenue
22.3.6 Geographical segmentation by revenue 2013
22.3.7 Business strategy
22.3.8 Key information
22.3.9 SWOT analysis
23. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market research methodology
Exhibit 2: Proteomics workflow overview
Exhibit 3: Proteomics technologies by laboratory applications
Exhibit 4: Proteomics technologies by healthcare applications
Exhibit 5: Proteomic-based biomarkers in various aspects of medicine
Exhibit 6: Technologies applied at various stages of proteomics process
Exhibit 7: Molecular diagnostic devices pricing influencers
Exhibit 8: Medicare perspective of diagnostic reimbursement
Exhibit 9: International associations dedicated to proteomics
Exhibit 10: Initiatives sponsored by Human Proteomics Organization
Exhibit 11: Key takeaways
Exhibit 12: Global proteomics market 2014-2019 ($ million)
Exhibit 13: Process workflow for characterization of human plasma proteome
Exhibit 14: Categorization of detected human plasma proteins (%)
Exhibit 15: Categorization of detected cellular proteins (%)
Exhibit 16: Categorization of detected classic plasma proteins (%)
Exhibit 17: Categorization of detected cytokine and related proteins (%)
Exhibit 18: Proteomics market for mass spectrometry 2014-2019 ($ million)
Exhibit 19: Proteomics market for 2-D electrophoresis 2014-2019 ($ million)
Exhibit 20: Proteomics market for protein biochips 2014-2019 ($ million)
Exhibit 21: Proteomics market for consumables 2014-2019 ($ million)
Exhibit 22: Segmentation of global proteomics market by geography 2014
Exhibit 23: Segmentation of global proteomics market by geography 2019
Exhibit 24: Segmentation of global proteomics market by geography 2014-2019
Exhibit 25: Proteomics market in Americas 2014-2019 ($ million)
Exhibit 26: Proteomics market in EMEA 2014-2019 ($ million)
Exhibit 27: Proteomics market in APAC 2014-2019 ($ million)
Exhibit 28: Agilent Technologies: business segmentation by revenue 2013
Exhibit 29: Agilent Technologies: business segmentation by revenue 2012 and 2013 ($ billion)
Exhibit 30: Agilent Technologies: geographical segmentation by revenue 2013
Exhibit 31: Danaher: Business Segmentation
Exhibit 32: Danaher: business segmentation 2013
Exhibit 33: Danaher: revenue by business segmentation 2012 and 2013 ($ million)
Exhibit 34: Danaher: revenue by geographical segmentation 2013
Exhibit 35: Thermo Fisher: business segmentation
Exhibit 36: Thermo Fisher: business segmentation by revenue 2013
Exhibit 37: Thermo Fisher: product segmentation by revenue 2013
Exhibit 38: Thermo Fisher: geographical segmentation by revenue 2013
